Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

January 2004

LifeCell Guides to 21% Revenue growth in Q4 2003 on strength of Soft Tissue Allograft sales BY ROBIN R. YOUNG CFA, JANUARY 26, 2004

LifeCell continues to post very impressive top line growth. Sales in the fourth quarter broke out of its sub-$10 million plateau and reached a solid $11.1 million. For the past six quarters LifeCell has been posting between $8-10 million in... more

Kensey Nash Announces 30% sales growth, 54% earnings growth BY JOHN MCCORMICK, JANUARY 26, 2004

Raises Fiscal 2004 Guidance. Ortho and sports medicine key growth driver. Biomaterials company Kensey Nash (KNSY) held a conference call to discuss its stellar Second Quarter earnings results last week. KNSY revenues were up 30% from $10.5 million to $13.7... more

Charite Artificial Disc FDA Approval Expected Mid-2005 – according to DePuy Spine BY ROBIN R. YOUNG CFA, JANUARY 26, 2004

In last week's JNJ conference call with analysts, management stated that its DePuy Spine division was expecting FDA approval for the Charité Artificial Disc in the United States by the first half of 2005. The Charité Disc, which was obtained... more

It's Almost Routine – Zimmer Crushes Analysts' Consensus Estimates... Again BY JOHN CHOPACK, JANUARY 26, 2004

Zimmer reported an abridged 4Q:03 financial report last week along with updated guidance for 2004. While many investors have come to expect Zimmer to exceed analyst expectations, we thought the 4Q:03 could represent the most difficult challenge for the Company... more

Osteotech Calls it Quits with SpineVision... Wall Street, for some reason, thinks that's a negative BY ROBIN R. YOUNG CFA, JANUARY 26, 2004

To quote from Dow Jones' press release, "Despite recording a $4.6 million profit in the first nine months of this year, Osteotech's metal spinal implant products have suffered big losses because an insufficient unit volume has failed to cover overhead... more

Is the IPO Market Back? BY ROBIN R. YOUNG CFA, JANUARY 12, 2004

Capital markets aren't rational. Otherwise, they'd have longer memories. A year ago, when Zimmer was trading at $40.01, DJ Orthopedics was at $3.66, Encore was at $3.20 and LifeCell was at $2.89, you couldn't buy an orthopedic or medical device... more

CryoLife Posts Anemic 4th Quarter / Predicts Comeback in 2004 BY ROBIN R. YOUNG CFA, JANUARY 12, 2004

4th Quarter revenues came in roughly $3 million under the third quarter's reported $15.1 million and certainly below our own expectations for the quarter. Revenues for the December quarter were approximately $12.8 million, up slightly from the prior year's $12.2... more

FDA Orthopedic Panel recommends spine cages be down-classified — 510(k) approvals now possible BY ROBIN R. YOUNG CFA, JANUARY 2, 2004

The FDA's orthopedic panel met this past December 11th and recommended that the FDA reclassify intervertebral body cages from a Class III to a Class II medical device. Class III devices are defined as life sustaining or life supporting devices... more

New York Times Caves In to Market Forces - Attempts Major Surgery on Spine Industry BY ROBIN R. YOUNG CFA, JANUARY 2, 2004

An estimated twenty five million people will have back pain severe enough to seek medical attention in the United States this year. Roughly 1% of them will also have spine fusion surgery. And, according to the New York Times in... more

Complete Archive